Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Adverse drug reactions

Online module aims to improve reporting of adverse drug reactions

yellow card adverse drug reaction reporting

Source: Medicines and Healthcare products Regulatory Agency

The new Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) e-learning module aims to bring awareness of adverse drug reaction reporting, such as the Yellow Card Scheme, to a Europe-wide audience

A 45-minute e-learning module targeted at improving the reporting of suspected adverse drug reactions (ADRs) has gained approval from the European Accreditation Council for Continuing Medical Education (EACCME).

Making medications safe relies on doctors and patients reporting ADRs, but according to the Medicines and Healthcare products Regulatory Agency (MHRA), there are issues with under-reporting.

A survey from the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action project, which created the new module, found that many countries lacked sustainable educational resources on ADR reporting.

The new module will see doctors awarded one EACCME credit on completion, a spokesperson from the MHRA told The Pharmaceutical Journal. This is equivalent to one hour’s continuing professional development (CPD) or continuing medical education (CME).

MHRA, which regulates medicines and medical devices in the UK, is leading the SCOPE Joint Action Project.

A spokesperon said: “Being vigilant not only in the prompt identification and reporting of suspected ADRs is important, but so is staying up-to-date with the latest safety information.”

The module follows on from an EU-wide ADR awareness raising week campaign that took place in November 2016, the spokesperson noted, which involved 21 medicine regulators across the EU. Regulators from Croatia, Ireland, Italy, Latvia, Lithuania and Romania have already encouraged use of the module, the spokesperson said.

Doctors in the UK can report ADRs online on the MHRA’s Yellow Card page and through clinical software systems such as systmOne and VISION. According to the MHRA spokesperson, ADR reports are increasing annually: 2016 saw 42,000 suspected ADR reports via the Yellow Card scheme, which is the highest to date, and the database now holds more than 820,000 records.

“We’ve created this e-learning module to help doctors so they can have confidence that their reports are making a difference,” said Mick Foy, group manager of the MHRA’s vigilance and risk management of medicines division in a statement published on 16 June 2017. “Doctors are critical to this as their position on the front line of care means they are often the first to recognise an adverse drug reaction.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203008

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • yellow card adverse drug reaction reporting

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.